These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27733504)

  • 1. Mechanistic determinants of MBNL activity.
    Sznajder ŁJ; Michalak M; Taylor K; Cywoniuk P; Kabza M; Wojtkowiak-Szlachcic A; Matłoka M; Konieczny P; Sobczak K
    Nucleic Acids Res; 2016 Dec; 44(21):10326-10342. PubMed ID: 27733504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
    André LM; van Cruchten RTP; Willemse M; Wansink DG
    PLoS One; 2019; 14(5):e0217317. PubMed ID: 31116797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs.
    Yuan Y; Compton SA; Sobczak K; Stenberg MG; Thornton CA; Griffith JD; Swanson MS
    Nucleic Acids Res; 2007; 35(16):5474-86. PubMed ID: 17702765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy.
    Wang PY; Lin YM; Wang LH; Kuo TY; Cheng SJ; Wang GS
    Hum Mol Genet; 2017 Jun; 26(12):2247-2257. PubMed ID: 28369378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2.
    Carpentier C; Ghanem D; Fernandez-Gomez FJ; Jumeau F; Philippe JV; Freyermuth F; Labudeck A; Eddarkaoui S; Dhaenens CM; Holt I; Behm-Ansmant I; Marmier-Gourrier N; Branlant C; Charlet-Berguerand N; Marie J; Schraen-Maschke S; Buée L; Sergeant N; Caillet-Boudin ML
    Biochim Biophys Acta; 2014 Apr; 1842(4):654-64. PubMed ID: 24440524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing.
    Pascual M; Vicente M; Monferrer L; Artero R
    Differentiation; 2006 Mar; 74(2-3):65-80. PubMed ID: 16533306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An engineered RNA binding protein with improved splicing regulation.
    Hale MA; Richardson JI; Day RC; McConnell OL; Arboleda J; Wang ET; Berglund JA
    Nucleic Acids Res; 2018 Apr; 46(6):3152-3168. PubMed ID: 29309648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation.
    Choi J; Personius KE; DiFranco M; Dansithong W; Yu C; Srivastava S; Dixon DM; Bhatt DB; Comai L; Vergara JL; Reddy S
    EBioMedicine; 2015 Sep; 2(9):1034-47. PubMed ID: 26501102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity.
    Terenzi F; Ladd AN
    RNA Biol; 2010; 7(1):43-55. PubMed ID: 20009516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy.
    Thomas JD; Sznajder ŁJ; Bardhi O; Aslam FN; Anastasiadis ZP; Scotti MM; Nishino I; Nakamori M; Wang ET; Swanson MS
    Genes Dev; 2017 Jun; 31(11):1122-1133. PubMed ID: 28698297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
    Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
    Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
    Dansithong W; Paul S; Comai L; Reddy S
    J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects.
    Hoskins JW; Ofori LO; Chen CZ; Kumar A; Sobczak K; Nakamori M; Southall N; Patnaik S; Marugan JJ; Zheng W; Austin CP; Disney MD; Miller BL; Thornton CA
    Nucleic Acids Res; 2014 Jun; 42(10):6591-602. PubMed ID: 24799433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy.
    Sznajder ŁJ; Swanson MS
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31323950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zebrafish mbnl mutants model physical and molecular phenotypes of myotonic dystrophy.
    Hinman MN; Richardson JI; Sockol RA; Aronson ED; Stednitz SJ; Murray KN; Berglund JA; Guillemin K
    Dis Model Mech; 2021 Jun; 14(6):. PubMed ID: 34125183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing of the neurofibromatosis type 1 pre-mRNA is regulated by the muscleblind-like proteins and the CUG-BP and ELAV-like factors.
    Fleming VA; Geng C; Ladd AN; Lou H
    BMC Mol Biol; 2012 Dec; 13():35. PubMed ID: 23227900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscleblind isoforms are functionally distinct and regulate alpha-actinin splicing.
    Vicente M; Monferrer L; Poulos MG; Houseley J; Monckton DG; O'dell KM; Swanson MS; Artero RD
    Differentiation; 2007 Jun; 75(5):427-40. PubMed ID: 17309604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MBNL expression in autoregulatory feedback loops.
    Konieczny P; Stepniak-Konieczna E; Sobczak K
    RNA Biol; 2018 Jan; 15(1):1-8. PubMed ID: 28949831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
    de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
    Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.